Clifton Leaf
New York Times
Researchers are coming to understand just how individualized human physiology and human pathology really are. That’s one reason that, despite the rigorous monitoring of clinical trials, 16 novel medicines were withdrawn from the market from 2000 through 2010, a figure equal to 6 percent of the total approved during the period. The pharmacogenomics of each of us — the way our genes influence our response to drugs — is unique.
Spread the word